JX (Jaxon) Tan

Opinion author

JX (Jaxon) Tan founded Momentum AI Communications, a boutique PR consultancy based in Singapore, with a mission to simplify science and spark engagement. He was previously based in China, where he led international communications for a leading biotech company and was head of content (APAC) for PR Newswire. Reach him on LinkedIn.

Pictured: Collage of a dragon, congress, and money

Opinion

BIOSECURE Act Threatens Already Strained U.S. Supply Chain

As Congress considers a bill that aims to distance U.S. biopharma from five Chinese companies, the industry must emphasize the importance of prioritizing patient care over power plays.

September 9, 2024

3 min read

JX (Jaxon) Tan

Policy

Opinion: As More Companies Are Targeted by BIOSECURE Act, Investor Relations Crisis Brews

The House Select Committee asks the FBI for a briefing on GenScript’s links to China, fueling the challenge facing public relations and investor relations teams at US biopharma firms and Chinese CDMOs.

June 11, 2024

4 min read

JX (Jaxon) Tan

Pictured: Dragon and eagle flank a throne of swords

Policy

Opinion: Chinese CDMOs and US Biopharma PR Strike a Precarious Balance

The PR departments of Chinese CDMOs affected by the BIOSECURE Act and their U.S. partners must step up to ensure proposed legislation doesn’t squash innovation.

May 21, 2024

5 min read

JX (Jaxon) Tan